Literature DB >> 12635792

Factors predisposing to dislocation of the Thompson hemiarthroplasty: 22 dislocations in 338 patients.

Jarkko Pajarinen1, Vesa Savolainen, Ilkka Tulikoura, Jan Lindahl, Eero Hirvensalo.   

Abstract

In a series of 338 patients, we have retrospectively analyzed technical and anatomical factors, which may predispose to a dislocation of the Thompson hemiprosthesis. 22 patients (7%) had at least 1 dislocation during the 6-month follow-up. The most significant independent factor predisposing to dislocation was the use of a posterior approach (dislocation rate 16%). We examined the radiographs and data on operations in the 22 patients, using 79 random patients without dislocation as controls. Factors correlating with an increase in the incidence of dislocation were the length of the residual femoral neck > 0.5 cm in short patients (< 165 cm), and considerable change in the postoperative offset of the hip. Acetabular measurements showed no correlation to the dislocation. Our findings suggest that the main factors predicting dislocation are technical and not related to anatomical measurements.

Entities:  

Mesh:

Year:  2003        PMID: 12635792     DOI: 10.1080/00016470310013644

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  27 in total

1.  Dislocation of hip hemiarthroplasty following posterolateral surgical approach: a nested case-control study.

Authors:  Rami Madanat; Tatu J Mäkinen; Mikko T Ovaska; Martti Soiva; Tero Vahlberg; Jussi Haapala
Journal:  Int Orthop       Date:  2011-09-20       Impact factor: 3.075

2.  Does surgical approach influence component positioning with Birmingham Hip Resurfacing?

Authors:  G J C Myers; D Morgan; C W McBryde; K O'Dwyer
Journal:  Int Orthop       Date:  2007-10-30       Impact factor: 3.075

3.  Is the dislocation rate higher after bipolar hemiarthroplasty in patients with neuromuscular diseases?

Authors:  Kuen Tak Suh; Dae Woong Kim; Hong Seok Lee; Yoon Jae Seong; Jung Sub Lee
Journal:  Clin Orthop Relat Res       Date:  2011-10-21       Impact factor: 4.176

4.  Unipolar versus bipolar Exeter hip hemiarthroplasty: a prospective cohort study on 830 consecutive hips in patients with femoral neck fractures.

Authors:  Anders Enocson; Carl Johan Hedbeck; Hans Törnkvist; Jan Tidermark; Lasse J Lapidus
Journal:  Int Orthop       Date:  2011-07-26       Impact factor: 3.075

5.  Predictors and outcomes of treatment in hip hemiarthroplasty dislocation.

Authors:  K M I Salem; O A Shannak; B E Scammell; C G Moran
Journal:  Ann R Coll Surg Engl       Date:  2014-09       Impact factor: 1.891

6.  Cemented Thompson's hemiarthroplasty in patients with intracapsular neck of femur fractures: survival analysis of 1,670 procedures.

Authors:  S K Khan; S S Jameson; A Sims; J A'Court; M R Reed; A Rangan; S D Muller
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-09-27

7.  CORR Insights®: What Are the Risk Factors for Dislocation of Hip Bipolar Hemiarthroplasty Through the Anterolateral Approach? A Nested Case-control Study.

Authors:  Eckart Mayr
Journal:  Clin Orthop Relat Res       Date:  2016-09-28       Impact factor: 4.176

8.  What Are the Risk Factors for Dislocation of Hip Bipolar Hemiarthroplasty Through the Anterolateral Approach? A Nested Case-control Study.

Authors:  Lianhua Li; Jixin Ren; Jia Liu; Hao Wang; Qinghua Sang; Zhi Liu; Tiansheng Sun
Journal:  Clin Orthop Relat Res       Date:  2016-08-30       Impact factor: 4.176

9.  Quality of life after dislocation of hip arthroplasty: a prospective cohort study on 319 patients with femoral neck fractures with a one-year follow-up.

Authors:  Anders Enocson; Hans Pettersson; Sari Ponzer; Hans Törnkvist; Nils Dalén; Jan Tidermark
Journal:  Qual Life Res       Date:  2009-08-28       Impact factor: 4.147

10.  Direction of hip arthroplasty dislocation in patients with femoral neck fractures.

Authors:  Anders Enocson; Gunilla Lapidus; Hans Törnkvist; Jan Tidermark; Lasse J Lapidus
Journal:  Int Orthop       Date:  2010-01-22       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.